# A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia

> **NCT00922389** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Beike Biotech India Pvt.ltd** · enrollment: 36 (estimated)

## Conditions studied

- Diabetic Foot
- Critical Limb Ischemia
- Leg Ulcers

## Interventions

- **PROCEDURE:** will receive G-CSF and peripheral blood derived mononuclear cells
- **DRUG:** G-CSF
- **DRUG:** Standard Therapy

## Key facts

- **NCT ID:** NCT00922389
- **Lead sponsor:** Beike Biotech India Pvt.ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-07
- **Primary completion:** 2010-01
- **Final completion:** 2011-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2009-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00922389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00922389, "A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00922389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*